Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.36-$1.21 |
Market Cap | $235.2M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $9.5M |
Revenue Growth (YoY) | 4% |
Gross Profit (12 Mos) | -$3.2M |
Diluted EPS | -$0.17 |
News
See moreYahoo Finance • 3 days ago
Lineage Cell Revenue Doubles in Q2
Yahoo Finance • 3 days ago
Lineage signals expanded diversification strategy following OpRegen milestones and $42.3M cash position
Yahoo Finance • 3 days ago
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
OpRegen ® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
CFO | Ms. Jill Ann Howe |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
